Canadian Cancer Trials Group Bulletins

Trial Management Group

Trial Closed to Accrual

We are very pleased to announce that SC.23 - A Randomized Phase III Double Blind Study of Dexamethasone Versus Placebo in the Prophylaxis of Radiation-Induced Pain Flare Following Palliative Radiotherapy for Bone Metastases - was closed to accrual on December 12, 2014.

This trial, which was only open in Canada, met its accrual goal of 298 patients. It is expected that all patients will complete protocol treatment no later than December 23, 2014.

Thank you to everyone who has worked on this trial.